Filing Details
- Accession Number:
- 0001553023-20-000007
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-02-05 18:33:47
- Reporting Period:
- 2020-02-03
- Accepted Time:
- 2020-02-05 18:33:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1553023 | Cyrusone Inc. | CONE | Real Estate Investment Trusts (6798) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1567001 | L Kevin Timmons | C/O Cyrusone Inc. 2850 N Harwood St, Suite 2200 Dallas TX 75201-2640 | Evp & Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-02-03 | 2,573 | $36.99 | 46,306 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-02-03 | 5,000 | $60.79 | 41,306 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2020-02-03 | 2,573 | $0.00 | 2,573 | $36.99 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
26,039 | 2026-02-01 | No | 4 | M | Direct |
Footnotes
- These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2019.
- Column 5 has been reduced to reflect the forfeiture of performance-based restricted stock awards for which the applicable performance criteria was not met.
- The option, representing a right to purchase a total of 28,612 shares, became exercisable in three equal annual installments beginning on February 1, 2017.